Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages

International Journal of Pharmaceutics

Volumn 196, Issue 2, 2000, Pages 253-256

  Kayser, O ^a  

^a Institut fur Pharmazie   (Germany)

Author keywords

Antiprotozoal; Aphidicolin; Drug targeting; Leishmania; Nanosuspension

Indexed keywords

AMPHOTERICIN B; APHIDICOLIN; ATOVAQUONE; DIMETHYL SULFOXIDE; NANOPARTICLE; PENTAMIDINE ISETHIONATE; POLYSORBATE 80;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG TARGETING; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SUSPENSION;

ANIMALS; ANTIPROTOZOAL AGENTS; APHIDICOLIN; BONE MARROW CELLS; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; INHIBITORY CONCENTRATION 50; LEISHMANIA; MACROPHAGES; MICE; MICE, INBRED C57BL; POLYSORBATES; SUSPENSIONS;

EID: 0033970268     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00434-2     Document Type: Article

References (4)

1. Kayser O., Kiderlen A.F., Folkens U., Kolodziej H. Antileishmia activity of aurones. Planta Med. 65:1999;316-319.
2. Kreuter J. Liposomes and nanoparticles as vehicles for antibiotics. Infection. 29 (Suppl 4):1991;S224-S228.
3. Müller R.H., Peters K. Nanosuspensions for the formulation poorly of soluble drugs, I. Preparation by a size reducing technique. Int. J. Pharm. 160:1998;229-237.
4. WHO, 1993. Report on the Joint WHO/MZCP/HPI Workshop on the Epidemiology. Diagnosis and Control of Leishmaniasis in the Mediterranean Area, Athens.